Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study

Benoit Gachet, M. Jouvray, V. Koether, A. Collet, S. Morell-Dubois, S. Sanges, V. Sobanski, E. Hachulla, David Launay
{"title":"Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study","authors":"Benoit Gachet, M. Jouvray, V. Koether, A. Collet, S. Morell-Dubois, S. Sanges, V. Sobanski, E. Hachulla, David Launay","doi":"10.1177/23971983241238921","DOIUrl":null,"url":null,"abstract":"Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and causes of anemia in systemic sclerosis. The objectives of our study were to determine the frequency and causes of anemia in systemic sclerosis, to analyze the clinical and biological characteristics of patients with anemia, and to assess the association between anemia and systemic sclerosis prognosis. We conducted a prospective single-center study from January 2017 to May 2022. Patients underwent a hemoglobin assay and a standardized etiological workup to determine the causes of anemia at the initial visit. Clinical and biological parameters were compared between patients with anemia and those with normal hemoglobin levels. We followed up patients until May 2023 and compared their survival. A total of 502 systemic sclerosis patients, including 107 diffuse cutaneous systemic sclerosis, were included. At enrollment, 100 patients had anemia. The primary cause of anemia was iron deficiency (40%). Among the 32 patients with iron deficiency-associated anemia who underwent gastrointestinal exploration, 56% had digestive bleeding, with upper gastrointestinal tract involvement being the main cause (90%). Patients with anemia at enrollment had higher systemic sclerosis severity scores and more gastrointestinal symptoms compared to patients without anemia (p < 0.05). They exhibited higher systolic pulmonary artery pressure, lower anemia-corrected diffusing capacity for carbon monoxide, and lower forced vital capacity (p < 0.05). During follow-up, 65 patients (14.8%) died. After adjusting for age, systemic sclerosis subtypes, forced vital capacity, and pulmonary arterial hypertension, anemia at inclusion was associated with a higher mortality rate (hazard ratio: 1.94 (95% confidence interval: 1.39–2.48), p = 0.02). Our study shows a high frequency of anemia among patients with systemic sclerosis. Most anemias are due to iron deficiency, and gastrointestinal exploration can identify bleeding in the majority of the cases. In addition, our study confirms that systemic sclerosis patients with anemia have a more severe disease and a higher mortality rate.","PeriodicalId":506053,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":"64 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241238921","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and causes of anemia in systemic sclerosis. The objectives of our study were to determine the frequency and causes of anemia in systemic sclerosis, to analyze the clinical and biological characteristics of patients with anemia, and to assess the association between anemia and systemic sclerosis prognosis. We conducted a prospective single-center study from January 2017 to May 2022. Patients underwent a hemoglobin assay and a standardized etiological workup to determine the causes of anemia at the initial visit. Clinical and biological parameters were compared between patients with anemia and those with normal hemoglobin levels. We followed up patients until May 2023 and compared their survival. A total of 502 systemic sclerosis patients, including 107 diffuse cutaneous systemic sclerosis, were included. At enrollment, 100 patients had anemia. The primary cause of anemia was iron deficiency (40%). Among the 32 patients with iron deficiency-associated anemia who underwent gastrointestinal exploration, 56% had digestive bleeding, with upper gastrointestinal tract involvement being the main cause (90%). Patients with anemia at enrollment had higher systemic sclerosis severity scores and more gastrointestinal symptoms compared to patients without anemia (p < 0.05). They exhibited higher systolic pulmonary artery pressure, lower anemia-corrected diffusing capacity for carbon monoxide, and lower forced vital capacity (p < 0.05). During follow-up, 65 patients (14.8%) died. After adjusting for age, systemic sclerosis subtypes, forced vital capacity, and pulmonary arterial hypertension, anemia at inclusion was associated with a higher mortality rate (hazard ratio: 1.94 (95% confidence interval: 1.39–2.48), p = 0.02). Our study shows a high frequency of anemia among patients with systemic sclerosis. Most anemias are due to iron deficiency, and gastrointestinal exploration can identify bleeding in the majority of the cases. In addition, our study confirms that systemic sclerosis patients with anemia have a more severe disease and a higher mortality rate.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
系统性硬化症患者贫血的患病率、原因和临床关联:一项队列研究
贫血被认为是系统性硬化症病情严重的一个风险因素。然而,关于系统性硬化症患者贫血的频率和原因的数据却很有限。我们的研究旨在确定系统性硬化症患者贫血的频率和原因,分析贫血患者的临床和生物学特征,并评估贫血与系统性硬化症预后之间的关联。我们于2017年1月至2022年5月开展了一项前瞻性单中心研究。患者在初诊时接受血红蛋白检测和标准化病因检查,以确定贫血的原因。我们比较了贫血患者和血红蛋白水平正常患者的临床和生物参数。我们对患者进行了随访,直至 2023 年 5 月,并比较了他们的存活率。共纳入 502 名系统性硬化症患者,其中包括 107 名弥漫性皮肤系统性硬化症患者。入组时,100 名患者患有贫血。贫血的主要原因是缺铁(40%)。在 32 名接受胃肠道检查的缺铁性贫血患者中,56% 有消化道出血,上消化道受累是主要原因(90%)。与无贫血患者相比,入院时有贫血的患者系统性硬化严重程度评分更高,胃肠道症状更多(P < 0.05)。他们的肺动脉收缩压较高,贫血校正后的一氧化碳弥散能力较低,用力肺活量也较低(P < 0.05)。在随访期间,65 名患者(14.8%)死亡。在对年龄、系统性硬化症亚型、强迫生命容量和肺动脉高压进行调整后,纳入时贫血与较高的死亡率相关(危险比:1.94(95% 置信区间:1.39-2.48),P = 0.02)。我们的研究表明,系统性硬化症患者贫血的发生率很高。大多数贫血是由于缺铁引起的,而胃肠道检查可以发现大多数病例有出血现象。此外,我们的研究还证实,患有贫血症的系统性硬化症患者病情更严重,死亡率更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Troponin I levels in systemic sclerosis patients with myocardial involvement Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists Resilience partially mediates the association between perceived social isolation and life satisfaction in people with systemic sclerosis Oral abstracts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1